Reports for TEVA-IRBESARTAN HCTZ
Brand name
TEVA-IRBESARTAN HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02330512 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
12.5 MG 150 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2019-07-02 | 2019-11-01 | 88174 |
| TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
Showing 1 to 3 of 3
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0